Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Int J Cell Biol ; 2012: 172746, 2012.
Article in English | MEDLINE | ID: mdl-22481943

ABSTRACT

A novel perivascular adventitial cell termed, adventitial neuronal somata (ANNIES) expressing the neural cell adhesion molecule (NCAM) and the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP), exists in the adult rat mesenteric branch artery (MBA) in situ. In addition, we have previously shown that ANNIES coexpress CGRP and NCAM. We now show that ANNIES express the neurite growth marker, growth associated protein-43(Gap-43), palladin, and the calcium sensing receptor (CaSR), that senses changes in extracellular Ca(2+) and participates in vasodilator mechanisms. Thus, a previously characterized vasodilator, calcium sensing autocrine/paracrine system, exists in the perivascular adventitia associated with neural-vascular interface. Images of the whole mount MBA segments were analyzed under scanning confocal microscopy. Confocal analysis showed that the Gap-43, CaSR, and palladin were present in ANNIES about 37 ± 4%, 94 ± 6%, and 80 ± 10% respectively, comparable to CGRP (100%). Immunoblots from MBA confirmed the presence of Gap-43 (48 kD), NCAM (120 and 140 kD), and palladin (90-92 and 140 kD). In summary, CGRP, and NCAM-containing neural cells in the perivascular adventitia also express palladin and CaSR, and coexpress Gap-43 which may participate in response to stress/injury and vasodilator mechanisms as part of a perivascular sensory neural network.

2.
Ethn Dis ; 18(3): 289-93, 2008.
Article in English | MEDLINE | ID: mdl-18785441

ABSTRACT

OBJECTIVES: African Americans as a group have higher blood pressure than individuals of northern European ancestry (non-Hispanic Whites). We investigate whether psychosocial factors explain the resting blood pressure of healthy, community-dwelling African Americans in our study. PARTICIPANTS: A convenience sample of self-reported normotensive African Americans aged 18-65 years who live in the North Carolina Triangle region. DESIGN: The study protocol consisted of three resting blood pressure sessions with assessment of the following psychosocial factors: anger expression, interpersonal support, anxiety, depression, hostility, active coping, and perceived racism. Additional clinical assessments were height, weight, waist girth, fasting glucose, insulin, triglycerides, and cholesterol. RESULTS: Resting systolic blood pressure was positively associated with male sex (P<.001) and positively correlated with age (P<.0001), waist girth (P<.0001), body mass index (P=.023), and a Cook Medley Hostility subscale identified as aggressive responding (P=.031). Mean arterial pressure was positively correlated with age (P<.0001), waist girth (P=.0041), Spielberger Anger Expression subscale anger control (P=.023), and aggressive responding (P=.020). CONCLUSIONS: Anger and hostility are significantly associated with resting blood pressure and may modulate behavioral and traditional (biologic) risk factors that determine cardiovascular physiology.


Subject(s)
Black or African American/psychology , Blood Pressure , Adolescent , Adult , Aged , Cohort Studies , Expressed Emotion/physiology , Female , Humans , Male , Middle Aged , North Carolina , Regression Analysis , Rest , Risk Factors , Social Behavior , Stress, Psychological/ethnology , Stress, Psychological/physiopathology
3.
Am J Hypertens ; 21(7): 814-9, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18451809

ABSTRACT

BACKGROUND: Although thiazides increase urinary sodium excretion, they also decrease urinary calcium excretion. Recent studies in our laboratory have shown that increased dietary salt significantly reduces interstitial fluid calcium in Dahl salt-sensitive (DS) rats, and this was associated with a rise in blood pressure and increased urinary calcium excretion. Owing to the vasorelaxant actions of increased extracellular fluid calcium, we reasoned that the antihypertensive action of hydrochlorothiazide (HCTZ), a commonly used thiazide, may be the result of increased interstitial fluid calcium as a consequence of decreased urinary calcium excretion. METHODS: To test this hypothesis, DS and Dahl salt-resistant (DR) rats were given high salt alone or in combination with HCTZ for 1 week. Renal cortical interstitial fluid calcium was determined by the zero net flux method. RESULTS: High salt decreased cortical interstitial fluid calcium (1.69 +/- 0.25 vs. 1.13 +/- 0.05 mmol/l; P < 0.05) in DS rats as previously reported; thiazide treatment had no effect on the high salt interstitial fluid calcium response in salt-sensitive animals. However, thiazide decreased interstitial fluid calcium in DS on a normal salt diet. Cortical interstitial fluid calcium was unchanged by dietary salt in DR rats, and thiazide did not alter this interstitial fluid calcium response. CONCLUSION: We interpret these data to mean that (i) short-term thiazide treatment does not reduce blood pressure by restoring renal cortical interstitial fluid calcium concentration and (ii) a decrease in renal cortical interstitial fluid calcium may not contribute to the increased renal vasoconstriction seen in salt-sensitivity.


Subject(s)
Antihypertensive Agents/pharmacology , Calcium/metabolism , Diuretics/pharmacology , Extracellular Fluid/metabolism , Hydrochlorothiazide/pharmacology , Hypertension/drug therapy , Kidney Cortex/drug effects , Animals , Blood Pressure/drug effects , Calcium/urine , Hypertension/etiology , Hypertension/metabolism , Hypertension/physiopathology , Kidney Cortex/metabolism , Kidney Cortex/physiopathology , Male , Rats , Rats, Inbred Dahl , Sodium Chloride, Dietary , Time Factors
4.
Am J Physiol Heart Circ Physiol ; 294(5): H2363-70, 2008 May.
Article in English | MEDLINE | ID: mdl-18375719

ABSTRACT

The perivascular sensory nerve (PvN) Ca(2+)-sensing receptor (CaR) is implicated in Ca(2+)-induced relaxation of isolated, phenylephrine (PE)-contracted mesenteric arteries, which involves the vascular endogenous cannabinoid system. We determined the effect of inhibition of diacylglycerol (DAG) lipase (DAGL), phospholipase A(2) (PLA(2)), and cytochrome P-450 (CYP) on Ca(2+)-induced relaxation of PE-contracted rat mesenteric arteries. Our findings indicate that Ca(2+)-induced vasorelaxation is not dependent on the endothelium. The DAGL inhibitor RHC 802675 (1 microM) and the CYP and PLA(2) inhibitors quinacrine (5 microM) (EC(50): RHC 802675 2.8 +/- 0.4 mM vs. control 1.4 +/- 0.3 mM; quinacrine 4.8 +/- 0.4 mM vs. control 2.0 +/- 0.3 mM; n = 5) and arachidonyltrifluoromethyl ketone (AACOCF(3), 1 microM) reduced Ca(2+)-induced relaxation of mesenteric arteries. Synthetic 2-arachidonoylglycerol (2-AG) and glycerated epoxyeicosatrienoic acids (GEETs) induced concentration-dependent relaxation of isolated arteries. 2-AG relaxations were blocked by iberiotoxin (IBTX) (EC(50): control 0.96 +/- 0.14 nM, IBTX 1.3 +/- 0.5 microM) and miconazole (48 +/- 3%), and 11,12-GEET responses were blocked by IBTX (EC(50): control 55 +/- 9 nM, IBTX 690 +/- 96 nM) and SR-141716A. The data suggest that activation of the CaR in the PvN network by Ca(2+) leads to synthesis and/or release of metabolites of the CYP epoxygenase pathway and metabolism of DAG to 2-AG and subsequently to GEETs. The findings indicate a role for 2-AG and its metabolites in Ca(2+)-induced relaxation of resistance arteries; therefore this receptor may be a potential target for the development of new vasodilator compounds for antihypertensive therapy.


Subject(s)
Arachidonic Acids/metabolism , Calcium/metabolism , Cytochrome P-450 Enzyme System/metabolism , Glycerides/metabolism , Mesenteric Arteries/metabolism , Receptors, Calcium-Sensing/metabolism , Signal Transduction , Vasodilation , 8,11,14-Eicosatrienoic Acid/metabolism , Acetylcholine/pharmacology , Animals , Arachidonic Acids/pharmacology , Cytochrome P-450 Enzyme Inhibitors , Dose-Response Relationship, Drug , Endocannabinoids , Enzyme Inhibitors/pharmacology , Lipoprotein Lipase/antagonists & inhibitors , Lipoprotein Lipase/metabolism , Male , Mesenteric Arteries/drug effects , Mesenteric Arteries/enzymology , Miconazole/pharmacology , Peptides/pharmacology , Phenylephrine/pharmacology , Phospholipase A2 Inhibitors , Phospholipases A2/metabolism , Piperidines/pharmacology , Potassium Channel Blockers/pharmacology , Potassium Channels, Calcium-Activated/antagonists & inhibitors , Potassium Channels, Calcium-Activated/metabolism , Pyrazoles/pharmacology , Quinacrine/pharmacology , Rats , Rats, Wistar , Receptor, Cannabinoid, CB1/antagonists & inhibitors , Receptor, Cannabinoid, CB1/metabolism , Rimonabant , Signal Transduction/drug effects , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology
5.
Calcif Tissue Int ; 82(1): 57-65, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18175029

ABSTRACT

Extracellular Ca2+ regulates dentin formation, but little information is available on this regulatory mechanism. We have previously reported that sensory denervation reduces dentin formation, suggesting a role for sensory nerves in tooth mineralization. The G protein-coupled Ca2+-sensing receptor (CaR) is expressed in dorsal root ganglia and perivascular sensory nerves in mesenteric arterioles, and activation of these receptors by Ca2+ has been shown to induce vascular relaxation. The present study determined CaR expression in tooth dental pulp (DP), sensory axons, and trigeminal ganglion (TG) as well as the effect of increased [Ca2+]e or a calcimimetic on tooth blood flow. The distribution of CaR, studied by immunochemistry, RT-PCR, and Western blot, indicates abundant expression of CaR in sensory axons in the jaws, TG, and DP. Restriction analysis of PCR products with specific endonucleases showed the presence of CaR message in TG and DP, and Western blotting indicates the expression of mature and immature forms of the receptor in these tissues. Pulpal blood flow, measured by laser-Doppler flowmetry, increased by 67% +/- 6% (n = 12) following receptor stimulation with 5 mM Ca2+, which was completely inhibited by 5 microM IBTx, a high-conductance KCa channel blocker indicating a mechanism involving hyperpolarization. NPS R-467 (10 microM) increased blood flow by 85% +/- 18% (n = 6), suggesting regulation through the CaR. Our results suggest that the CaR is present in sensory nerves, DP, and TG and that an increase in Ca2+ in the DP causes vasodilatation, which may contribute to accumulation of Ca2+ during dentin mineralization.


Subject(s)
Axons/metabolism , Dental Pulp/innervation , Receptors, Calcium-Sensing/metabolism , Sensory Receptor Cells/metabolism , Tooth/innervation , Trigeminal Ganglion/metabolism , Animals , Arterioles/metabolism , Calcification, Physiologic/physiology , Calcium/metabolism , Calcium/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Signaling/drug effects , Calcium Signaling/physiology , Cells, Cultured , Dental Pulp/metabolism , Laser-Doppler Flowmetry , Male , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, Calcium-Sensing/genetics , Regional Blood Flow/drug effects , Regional Blood Flow/physiology , Sensory Receptor Cells/drug effects , Tooth/blood supply , Tooth/growth & development , Trigeminal Ganglion/cytology , Vasodilation/drug effects , Vasodilation/physiology
6.
Am J Physiol Cell Physiol ; 292(5): C1895-905, 2007 May.
Article in English | MEDLINE | ID: mdl-17267550

ABSTRACT

The rat dorsal root ganglion (DRG) Ca(2+)-sensing receptor (CaR) was stably expressed in-frame as an enhanced green fluorescent protein (EGFP) fusion protein in human embryonic kidney (HEK)293 cells, and is functionally linked to changes in intracellular Ca(2+) concentration ([Ca(2+)](i)). RT-PCR analysis indicated the presence of the message for the DRG CaR cDNA. Western blot analysis of membrane proteins showed a doublet of 168-175 and 185 kDa, consistent with immature and mature forms of the CaR.EGFP fusion protein, respectively. Increasing extracellular [Ca(2+)] ([Ca(2+)](e)) from 0.5 to 1 mM resulted in increases in [Ca(2+)](i) levels, which were blocked by 30 microM 2-aminoethyldiphenyl borate. [Ca(2+)](e)-response studies indicate a Ca(2+) sensitivity with an EC(50) of 1.75 +/- 0.10 mM. NPS R-467 and Gd(3+) activated the CaR. When [Ca(2+)](e) was successively raised from 0.25 to 4 mM, peak [Ca(2+)](i), attained with 0.5 mM, was reduced by approximately 50%. Similar reductions were observed with repeated applications of 10 mM Ca(2+), 1 and 10 microM NPS R-467, or 50 and 100 microM Gd(3+), indicating desensitization of the response. Furthermore, Ca(2+) mobilization increased phosphorylated protein kinase C (PKC)alpha levels in the cells. However, the PKC activator, phorbol myristate acetate did not inhibit CaR-mediated Ca(2+) signaling. Rather, a spectrum of PKC inhibitors partially reduced peak responses to Ca(e)(2+). Treatment of cells with 100 nM PMA for 24 h, to downregulate PKC, reduced [Ca(2+)](i) transients by 49.9 +/- 5.2% (at 1 mM Ca(2+)) and 40.5 +/- 6.5% (at 2 mM Ca(2+)), compared with controls. The findings suggest involvement of PKC in the pathway for Ca(2+) mobilization following CaR activation.


Subject(s)
Calcium Signaling/drug effects , Calcium/metabolism , Ganglia, Spinal/metabolism , Protein Kinase C-alpha/metabolism , Receptors, Calcium-Sensing/metabolism , Aniline Compounds/pharmacology , Animals , Cell Line , Enzyme Activators/pharmacology , Gadolinium/metabolism , Green Fluorescent Proteins/genetics , Humans , Phosphorylation , Protein Kinase Inhibitors/pharmacology , RNA, Messenger/metabolism , Rats , Receptors, Calcium-Sensing/drug effects , Receptors, Calcium-Sensing/genetics , Recombinant Fusion Proteins/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Time Factors , Transfection
7.
J Vasc Res ; 43(3): 278-88, 2006.
Article in English | MEDLINE | ID: mdl-16636576

ABSTRACT

Confocal analysis of the whole-mount rat mesenteric branch arteries (MBA) revealed nucleated structures with axonal processes which immunostained for calcitonin gene-related peptide (CGRP). Immunocytochemistry ruled out the possibility that these were immune elements (macrophages and mast or dendritic cells) in close proximity with nerve fibers. To test our hypothesis that beta-CGRP is expressed in the rat MBA, we performed RT-PCR using total RNA isolated from the mesenteric artery arcade and intron spanning primers designed to amplify 188 bp of the beta-CGRP and 333 bp of alpha-CGRP cDNA. The PCR yielded an amplicon of the predicted size which was cloned into the pCR 3.1 vector. DNA sequence analysis of the insert showed 100% homology with the beta-CGRP cDNA, indicating that mRNA encoding beta-CGRP is expressed in the vessel. To learn whether neuronal cell bodies are located in the adventitia of MBA, we performed a limited collagenase digestion of isolated segments and plated the resulting cells in Ham's F12 medium with 10% horse serum on polyornithine-coated cover glasses. The medium was replaced after 48 h with Ham's F12 nutrient mixture containing N2 supplement. This resulted in a mixed population of fibroblasts, a small number of smooth muscle cells and a subset of cells that sprouted axons and immunostained positively for neuronal cell adhesion molecule and CGRP antigens. Fibroblasts and smooth muscle cells did not label with these antibodies. These data demonstrate, for the first time, that a population of adventitial neuronal somata (termed ANNIES), possibly of sensory nerve origin, is located in small mesenteric arteries.


Subject(s)
Calcitonin Gene-Related Peptide/analysis , Connective Tissue Cells/chemistry , Mesenteric Arteries/chemistry , Neurons/chemistry , Animals , Antigens, CD/analysis , Antigens, Differentiation/analysis , Antigens, Differentiation, Myelomonocytic/analysis , Base Sequence , Calcitonin Gene-Related Peptide/genetics , Cell Shape , Cells, Cultured , Histocompatibility Antigens Class II/analysis , Immunohistochemistry , Male , Microscopy, Confocal , Molecular Sequence Data , Neural Cell Adhesion Molecules/analysis , RNA, Messenger/analysis , Rats , Rats, Wistar , Receptors, Cell Surface/analysis , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA
8.
Circulation ; 110(14): 1996-2002, 2004 Oct 05.
Article in English | MEDLINE | ID: mdl-15451779

ABSTRACT

BACKGROUND: Endocannabinoids are novel lipid mediators with hypotensive and cardiodepressor activity. Here, we examined the possible role of the endocannabinergic system in cardiovascular regulation in hypertension. METHODS AND RESULTS: In spontaneously hypertensive rats (SHR), cannabinoid-1 receptor (CB1) antagonists increase blood pressure and left ventricular contractile performance. Conversely, preventing the degradation of the endocannabinoid anandamide by an inhibitor of fatty acid amidohydrolase reduces blood pressure, cardiac contractility, and vascular resistance to levels in normotensive rats, and these effects are prevented by CB1 antagonists. Similar changes are observed in 2 additional models of hypertension, whereas in normotensive control rats, the same parameters remain unaffected by any of these treatments. CB1 agonists lower blood pressure much more in SHR than in normotensive Wistar-Kyoto rats, and the expression of CB1 is increased in heart and aortic endothelium of SHR compared with Wistar-Kyoto rats. CONCLUSIONS: We conclude that endocannabinoids tonically suppress cardiac contractility in hypertension and that enhancing the CB1-mediated cardiodepressor and vasodilator effects of endogenous anandamide by blocking its hydrolysis can normalize blood pressure. Targeting the endocannabinoid system offers novel therapeutic strategies in the treatment of hypertension.


Subject(s)
Arachidonic Acids/pharmacology , Blood Pressure/drug effects , Dronabinol/analogs & derivatives , Hypertension/physiopathology , Myocardial Contraction/drug effects , Receptor, Cannabinoid, CB1/drug effects , Vascular Resistance/drug effects , Amidohydrolases/antagonists & inhibitors , Angiotensin II/toxicity , Animals , Arachidonic Acids/metabolism , Benzamides/pharmacology , Benzyl Compounds/pharmacology , Blood Pressure/physiology , Camphanes/pharmacology , Carbamates/pharmacology , Dronabinol/pharmacology , Endocannabinoids , Endothelium, Vascular/metabolism , Hypertension/chemically induced , Hypertension/genetics , Male , Models, Cardiovascular , Myocardial Contraction/physiology , Myocardium/metabolism , Piperidines/pharmacology , Polyunsaturated Alkamides , Pyrazoles/pharmacology , Rats , Rats, Inbred Dahl , Rats, Inbred SHR , Rats, Inbred WKY , Rats, Sprague-Dawley , Receptor, Cannabinoid, CB1/physiology , Rimonabant , Up-Regulation , Vascular Resistance/physiology , Vasodilation/drug effects , Vasodilation/physiology , Ventricular Function, Left/drug effects , Ventricular Function, Left/physiology
10.
Am J Hypertens ; 16(9 Pt 1): 771-6, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12944037

ABSTRACT

It is now established that cells in many tissues including renal epithelial cells and perivascular sensory nerves have mechanisms that monitor and respond to the concentration of Ca2+ in the interstitial compartment [Ca2+(ISF)]. We tested the hypothesis that high Na+ intake alters renal [Ca2+(ISF)] and that the response is altered in salt-sensitive hypertensive versus normotensive rats. Male Wistar (W), Dahl salt-resistant (DR), and Dahl salt-sensitive (DS) rats were fed diets containing 0.45% or 8% NaCl for 7 days beginning at 8 to 10 weeks of age. Systolic blood pressure (BP) was measured before and at the end of the 7-day period. During the last 12 h the animals were placed in metabolic cages for urine collection. They were then anesthetized and renal [Ca2+(ISF)] was determined using in situ microdialysis. Feeding 8% NaCl caused a significant increase in systolic BP only in DS. The 8% NaCl also caused a significant increase in renal urinary Na+ excretion in all groups, had no effect on renal Ca2+ excretion in W or DS and significantly increased urinary Ca2+ excretion in DR. When fed 0.45% NaCl, renal [Ca2+(ISF)] was lower in W and DR compared with DS. Feeding 8% NaCl significantly increased [Ca(ISF)] in W, had no effect on this parameter in DR, and significantly decreased [Ca2+(ISF)] in DS ([Ca2+(ISF)] for DS on 0.45% NaCl = 1.89 +/- 0.15 v 8% NaCl = 1.08 +/- 0.07 mmol/L, n = 6 to 12, P <.05). These results indicate that Na+ loading significantly alters renal [Ca2+(ISF)]; that the response of DS is disturbed relative to controls, and are consistent with the hypothesis that Na+ loading can alter cell function by modulating [Ca2+(ISF)].


Subject(s)
Calcium/metabolism , Extracellular Fluid/drug effects , Extracellular Fluid/metabolism , Hypertension/metabolism , Kidney/drug effects , Kidney/metabolism , Sodium, Dietary/administration & dosage , Animals , Biomarkers/urine , Blood Pressure/drug effects , Diet, Sodium-Restricted , Disease Models, Animal , Dose-Response Relationship, Drug , Male , Models, Cardiovascular , Natriuresis/drug effects , Rats , Rats, Inbred Dahl , Rats, Wistar , Statistics as Topic , Systole/drug effects
11.
Am J Physiol Cell Physiol ; 285(1): C64-75, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12637267

ABSTRACT

A full-length cDNA encoding a Ca2+-sensing receptor (CaSR) expressed in rat dorsal root ganglia (DRG) was identified using rapid amplification of 5'-cDNA ends and primer extension and then cloned into the plasmid vector pCR3.1. The DNA sequence of the DRG CaSR was 99.9% homologous with published rat kidney CaSR in the coding region and 247 bp upstream of the start site but showed little homology 5' to this site, which maps to exonic junction I/II, supporting the hypothesis that CaSR message arises as a splice variant and showing tissue-to-tissue heterogeneity. Western blot revealed a doublet of 140 and 160 kDa in a thyroparathyroid preparation and a single 140-kDa band in DRG. Deglycosylation using N-glycanase increased the mobility of CaSR protein from both DRG and thyroparathyroid, whereas endo-H was without effect, indicating that the DGR CaSR is a mature form of the receptor. A DRG CaSR-pEGFP fusion product was constructed, and when transfected into HEK-293 cells, it was distributed at the cell membrane and resulted in extracellular Ca2+ (0.5-3 mM)-evoked increases in intracellular Ca2+, which in some instances exhibited oscillatory behavior. We conclude that DRG CaSR cDNA arises from tissue-specific alternative splicing of a single gene, that the amino acid sequence of DRG CaSR is homologous to other known CaSRs, and that the DRG CaSR undergoes differential posttranslational processing relative to the thyroparathyroid CaSR and is functionally active when transfected into a human-derived cell line.


Subject(s)
Neurons, Afferent/physiology , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Animals , Base Sequence , Calcium/metabolism , Cloning, Molecular , DNA, Complementary , Ganglia, Spinal/cytology , Glycosylation , Male , Molecular Sequence Data , RNA Processing, Post-Transcriptional/physiology , Rats , Rats, Wistar , Receptors, Calcium-Sensing , Sequence Homology, Amino Acid
12.
Mol Pharmacol ; 63(3): 699-705, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12606780

ABSTRACT

The cannabinoid analog abnormal cannabidiol [abn-cbd; (-)-4-(3-3,4-trans-p-menthadien-[1,8]-yl)-olivetol] does not bind to CB(1) or CB(2) receptors, yet it acts as a full agonist in relaxing rat isolated mesenteric artery segments. Vasorelaxation by abn-cbd is endothelium-dependent, pertussis toxin-sensitive, and is inhibited by the BK(Ca) channel inhibitor charybdotoxin, but not by the nitric-oxide synthase inhibitor N(omega)-nitro-L-arginine methyl ester or by the vanilloid VR1 receptor antagonist capsazepine. The cannabidiol analog O-1918 does not bind to CB(1) or CB(2) receptors and does not cause vasorelaxation at concentrations up to 30 microM, but it does cause concentration-dependent (1-30 microM) inhibition of the vasorelaxant effects of abn-cbd and anandamide. In anesthetized mice, O-1918 dose-dependently inhibits the hypotensive effect of abn-cbd but not the hypotensive effect of the CB(1) receptor agonist (-)-11-OH-Delta(9)-tetrahydrocannabinol dimethylheptyl. In human umbilical vein endothelial cells, abn-cbd induces phosphorylation of p42/44 mitogen-activated protein kinase and protein kinase B/Akt, which is inhibited by O-1918, by pertussis toxin or by phosphatidylinositol 3 (PI3) kinase inhibitors. These findings indicate that abn-cbd is a selective agonist and that O-1918 is a selective, silent antagonist of an endothelial "anandamide receptor", which is distinct from CB(1) or CB(2) receptors and is coupled through G(i)/G(o) to the PI3 kinase/Akt signaling pathway.


Subject(s)
Cannabidiol/pharmacology , Endothelium, Vascular/physiology , GTP-Binding Proteins/metabolism , Receptor, Cannabinoid, CB2 , Receptors, Drug/physiology , Vasodilation/drug effects , Animals , Humans , In Vitro Techniques , Ligands , Male , Rats , Rats, Sprague-Dawley , Receptors, Cannabinoid
14.
Am J Hypertens ; 15(4 Pt 1): 310-5, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11991215

ABSTRACT

BACKGROUND: Type II diabetes in humans is associated with pathology of both the cardiovascular and peripheral sensory nervous systems. Because abnormal vasodilator responses have been reported in animals of type II diabetes and perivascular sensory nerves are a source of vasodilator substances, we tested the hypothesis that sensory nerve-dependent relaxation is abnormal in arteries of the Zucker diabetic fatty (ZDF) rat model of type II diabetes. METHODS: The ZDF rats and genetic controls were studied at 26 weeks of age. Tail-cuff systolic blood pressure (BP) was measured, serum was obtained for chemical determinations, and mesenteric branch arteries were isolated for wire myograph analysis and confocal-based measurement of calcitonin gene-related peptide (CGRP) positive nerve density. RESULTS: No differences in BP were detected. Serum glucose, triglycerides, and cholesterol were significantly elevated in ZDF. Sensory nerve-dependent vasodilation was assessed by measuring relaxation of phenylephrine preconstricted arterial segments to cumulative addition of divalent calcium ion (Ca2+) or capsaicin. Neither Ca(2+)-nor capsaicin-induced relaxation were different in ZDF versus control (maximal ZDF response to Ca2+ = 64% +/- 2% v 59% +/- 4%; ED50 for Ca2+ = 3.7 +/- 0.5 mmol/L v 3.2 +/- 0.5 mmol/L; n = 5, P = not significant [NS]; maximal ZDF response to capsaicin = 68% +/- 9% v 74% +/- 4%; ZDF ED50 = 3.8 +/- 0.5 nmol/L v 9.8 +/- 7 nmol/L; n = 5, P = NS). In contrast, the maximal relaxation response to acetylcholine was impaired in ZDF (maximal ZDF response = 83% +/- 5% v 94% +/- 2%, n = 4, P = .039; ED50 for acetylcholine = 8.1 +/- 2.9 nmol/L for ZDF v 33.5 +/- 18.2; n = 4 per group, P = .086). The CGRP positive nerve density was not different between groups. CONCLUSIONS: Blood pressure, perivascular sensory nerve CGRP content, and dilator function is normal in the ZDF model of type II diabetes, whereas endothelium-dependent relaxation is impaired.


Subject(s)
Arteries/innervation , Diabetes Mellitus, Type 2/physiopathology , Neurons, Afferent/physiology , Vasodilation , Acetylcholine/pharmacology , Animals , Arteries/chemistry , Calcitonin Gene-Related Peptide/analysis , Calcium/pharmacology , Capsaicin/pharmacology , Rats , Rats, Zucker
15.
Hypertension ; 39(2): 251-7, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11847193

ABSTRACT

Mesenteric branch arteries isolated from cannabinoid type 1 receptor knockout (CB(1)(-/-)) mice, their wild-type littermates (CB(1)(+/+) mice), and C57BL/J wild-type mice were studied to test the hypothesis that murine arteries undergo high sensitivity Ca(2+)-induced relaxation that is CB(1) receptor dependent. Confocal microscope analysis of mesenteric branch arteries from wild-type mice showed the presence of Ca(2+) receptor-positive periadventitial nerves. Arterial segments of C57 control mice mounted on wire myographs contracted in response to 5 micromol/L norepinephrine and responded to the cumulative addition of extracellular Ca(2+) with a concentration-dependent relaxation that reached a maximum of 72.0 +/- 6.3% of the prerelaxation tone and had an EC(50) for Ca(2+) of 2.90 +/- 0.54 mmol/L. The relaxation was antagonized by precontraction in buffer containing 100 mmol/L K(+) and by pretreatment with 10 mmol/L tetraethylammonium. Arteries from CB(1)(-/-) and CB(1)(+/+) mice also relaxed in response to extracellular Ca(2+) with no differences being detected between the knockout and their littermate controls. SR141716A, a selective CB(1) antagonist, caused concentration-dependent inhibition of Ca(2+)-induced relaxation in both the knockout and wild-type strains (60% inhibition at 1 micromol/L). O-1918, a cannabidiol analog, had a similar blocking effect in arteries of both wild-type and CB(1)(-/-) mice at 10 micromol/L. In contrast, 1 micromol/L SR144538, a cannabinoid type 2 receptor antagonist, or 50 micromol/L 18alpha-glycyrrhetinic acid, a gap junction blocker, were without effect. SR141716A (1 to 30 micromol/L) was also assessed for nonspecific actions on whole-cell K(+) currents in isolated vascular smooth muscle cells. SR141716A inhibited macroscopic K(+) currents at concentrations higher than those required to inhibit Ca(2+)-induced relaxation, and appeared to have little effect on currents through large conductance Ca(2+)-activated K(+) channels. These data indicate that arteries of the mouse relax in response to cumulative addition of extracellular Ca(2+) in a hyperpolarization-dependent manner and rule out a role for CB(1) or CB(2) receptors in this effect. The possible role of a nonclassical cannabinoid receptor is discussed.


Subject(s)
Calcium/pharmacology , Piperidines/pharmacology , Pyrazoles/pharmacology , Receptors, Drug/antagonists & inhibitors , Vasodilation/drug effects , Acetylcholine/pharmacology , Animals , Cricetinae , Dose-Response Relationship, Drug , Male , Membrane Potentials/drug effects , Mesenteric Arteries/drug effects , Mesenteric Arteries/physiology , Mesocricetus , Mice , Mice, Inbred C57BL , Mice, Knockout , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , Norepinephrine/pharmacology , Potassium Channels/physiology , Receptors, Cannabinoid , Receptors, Drug/genetics , Rimonabant , Tetraethylammonium/pharmacology , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...